CIK: 1312622 - Address: C/o Agios Pharmaceuticals, Inc., 88 Sidney Street, Cambridge, MA 02139
17 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret2141-21317-8-13
S%wins5075255010010067

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/11/24 16:09
3/7/24
AGIOAgios Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsFoster-Cheek Kaye IMADS-4131.620-1-148D
3/7/24 18:49
3/5/24
AGIOAgios Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsFoster-Cheek Kaye IMADS.m-15132.000-5-349D
8/11/23 16:04
8/9/23
AGIOAgios Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsFoster-Cheek Kaye IMADS.d-64925.960-25-6514D
6/18/18 16:05
6/14/18
AGIOAgios Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsFoster-Cheek Kaye IMADS.d-84293.550-9-802D
3/21/18 16:04
3/19/18
AGIOAgios Pharmaceuticals IncDEHealthDrugPharmaceutical PreparationsFoster-Cheek Kaye IMADS.d-55781.970-7-762D
8/8/13 20:21
8/6/13
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFoster-Cheek Kaye ICAOSVP,GlobS.d-1,179132.810-9-2527D
5/8/13 20:44
5/7/13
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFoster-Cheek Kaye ICAOSVP,GlobS.d-79789.840-9-2527D
4/3/13 19:51
4/1/13
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFoster-Cheek Kaye ICAOSVP,GlobS.m-33687.750-4-1227D
2/20/13 19:16
2/15/13
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFoster-Cheek Kaye ICAOSVP,GlobS.d-1,21274.960-16-3925D
11/8/12 19:56
11/6/12
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFoster-Cheek Kaye ICAOSVP,GlobS.d-54075.900-7-2225D
10/4/12 18:55
10/2/12
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFoster-Cheek Kaye ICAOSVP,GlobS-17185.080-2-728D
8/8/12 21:49
8/6/12
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFoster-Cheek Kaye ICAOSVP,GlobS.d-2,08070.490-30-4536D
7/27/12 20:21
7/25/12
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFoster-Cheek Kaye ICAOSVP,GlobS-17373.970-2-544D
12/7/11 20:29
12/5/11
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFoster-Cheek Kaye ICAOSVP,GlobS.d-1,28543.5633-30-5128D4427102718913-4-4-85-8
10/4/11 16:50
10/3/11
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFoster-Cheek Kaye ICAOSVP,GlobS-4829.7522-2-531D216-13-17-1-5-3-5422538
9/26/11 19:40
9/23/11
ONXXOnyx Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFoster-Cheek Kaye ICAOSVP,GlobS-5330.0023-2-533D-412-14-13-3-3-4-93-12137
12/11/09 14:45
12/10/09
JNJJohnson & JohnsonNJHealthDrugPharmaceutical PreparationsFoster-Cheek Kaye INJOVP,HRS.d-6,26564.7633-97-8023M21617895210000-8-1

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact